ATE167061T1 - Kreuzschützende salmonella impfstoffe - Google Patents

Kreuzschützende salmonella impfstoffe

Info

Publication number
ATE167061T1
ATE167061T1 AT90917076T AT90917076T ATE167061T1 AT E167061 T1 ATE167061 T1 AT E167061T1 AT 90917076 T AT90917076 T AT 90917076T AT 90917076 T AT90917076 T AT 90917076T AT E167061 T1 ATE167061 T1 AT E167061T1
Authority
AT
Austria
Prior art keywords
mutation
vaccines
salmonella
gene
possess
Prior art date
Application number
AT90917076T
Other languages
English (en)
Inventor
Roy Curtiss Iii
Maryann Munson
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE167061T1 publication Critical patent/ATE167061T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90917076T 1989-11-03 1990-11-02 Kreuzschützende salmonella impfstoffe ATE167061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43159789A 1989-11-03 1989-11-03

Publications (1)

Publication Number Publication Date
ATE167061T1 true ATE167061T1 (de) 1998-06-15

Family

ID=23712646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90917076T ATE167061T1 (de) 1989-11-03 1990-11-02 Kreuzschützende salmonella impfstoffe

Country Status (7)

Country Link
EP (1) EP0500699B1 (de)
JP (1) JPH05504331A (de)
AT (1) ATE167061T1 (de)
AU (1) AU6737190A (de)
CA (1) CA2072633A1 (de)
DE (1) DE69032408T2 (de)
WO (1) WO1991006317A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69322092T2 (de) * 1992-09-04 1999-07-15 University Of Saskatchewan, Saskatoon Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
WO1994025598A2 (en) * 1993-04-26 1994-11-10 University Of Victoria Innovation And Development Corporation Methods and compositions for salmonella-based vaccines
DE4333742A1 (de) * 1993-10-04 1995-04-06 Klaus Prof Dr Linde Lebendimpfstoff mit erhöhter Stabilität
US5922583A (en) * 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
CN1253551C (zh) 1997-09-10 2006-04-26 维昂药品公司 减毒的遗传修饰肿瘤靶向细菌
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
US6605285B2 (en) 2000-03-29 2003-08-12 G.B. Pant University Of Agriculture & Technology Vaccine for protection of poultry against salmonellosis and a process for preparing the same
EP2380440B1 (de) * 2002-04-15 2016-03-09 Washington University Geregelte Abschwächung von lebenden Impfstoffen zur Verbesserung der gekreuzten Schutzimmunogenität
WO2009025888A2 (en) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
WO2009046449A1 (en) 2007-10-05 2009-04-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
GB2483595B (en) 2009-05-22 2017-03-29 The Arizona Board Of Regents For And On Behalf Of Arizona State Univ Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
EP2526185A4 (de) 2010-01-22 2013-07-24 Univ Arizona Bakterium mit einer regulierten rfah-nukleinsäure
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
BRPI1003750A2 (pt) 2010-07-22 2012-04-10 Univ Sao Paulo microrganismos recombinantes, métodos de preparação de linhagens vacinais, antìgenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN112175928B (zh) * 2020-10-13 2022-09-13 华中农业大学 一种源于沙门氏菌噬菌体基因编码的蛋白在作为革兰氏阴性菌裂解酶中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249449A1 (de) * 1986-06-11 1987-12-16 Enterovax Research Pty. Ltd. Bakterieller Stamm für lebende Impfstoffe
WO1990011687A1 (en) * 1989-03-31 1990-10-18 Washington University VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS

Also Published As

Publication number Publication date
EP0500699A1 (de) 1992-09-02
CA2072633A1 (en) 1991-05-04
EP0500699B1 (de) 1998-06-10
DE69032408T2 (de) 1998-10-08
AU6737190A (en) 1991-05-31
DE69032408D1 (de) 1998-07-16
EP0500699A4 (en) 1993-04-28
JPH05504331A (ja) 1993-07-08
WO1991006317A1 (en) 1991-05-16

Similar Documents

Publication Publication Date Title
ATE167061T1 (de) Kreuzschützende salmonella impfstoffe
Udhayakumar et al. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice
Cryz Jr et al. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa
YU24391A (sh) Poboljšana meningokokna polisaharid kon-jugovana vakcina
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
ES8505719A1 (es) Procedimiento de preparar mutantes de delecion vivos y metodo de preparar vacunas
PT88329A (pt) Bacterias nao virulentas contra infeccoes estreptococicas
Ortiz et al. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever
IL97720A0 (en) Live vaccines
ATE242319T1 (de) Deletionsmutanten als impfstoffe gegen cholera
DE3476896D1 (en) Production of protein a
NO921729D0 (no) Stabile pura-vektorer og anvendelser derav
Nilsson et al. Two‐dimensional electrophoretic and immunoblot analysis of cell surface proteins of spiral‐shaped and coccoid forms of Helicobacter pylori
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
Jayappa et al. Role of Escherichia coli type 1 pilus in colonization of porcine ileum and its protective nature as a vaccine antigen in controlling colibacillosis
Chatfield et al. Identification of the major antigens of Treponema hyodysenteriae and comparison with those of Treponema innocens
Guirguis et al. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
Mintz et al. Electrophoretic and serological characterization of the lipopolysaccharide produced by Neisseria gonorrhoeae
Montie et al. Isolation and characterization of flagellar preparations from Pseudomonas species
ATE112320T1 (de) Sekretormutante von escherichia coli.
Lachmann et al. Solubilization and characterization of surface antigenic components of Erysipelothrix rhusiopathiae T28
Mansheim et al. Immunochemical differences between oral and nonoral strains of Bacteroides asaccharolyticus
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
Groschup et al. Modified Feist broth as a serum-free alternative for enhanced production of protective antigen of Erysipelothrix rhusiopathiae
Barton et al. Further characterization of Renibacterium salmoninarum extracellular products

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties